Botulinum toxin injection outcomes and side effects depend more on who injects, where, and how much than on the product name[1][2]Eyelid drooping is reported in 2.5–5.4% with less experienced injectors and 0.51–1% with experienced injectors.[1]Facial muscle thickness and depth vary between individuals, so whether the injector examines your muscle movement before treatment makes a difference.[3].
What changes with the injector's experience?
The most variable outcome is eyelid drooping. Less experienced injectors see 2.5–5.4%, while experienced injectors see 0.51–1%—a several-fold difference.[1].
Eyelid drooping occurs because the medication spreads to the muscles that lift the eyelid.[1]Causes include injection placement too close to the pupil, excessive volume, or injection that is too deep.[3]For the glabella and forehead, recommendations include staying at least 1 cm above the orbital rim, reducing volume within the effective range, and avoiding massage after injection.[4].
Expert discussions note that even slight differences in injection placement produce significantly different results, and that a learning curve is required.[2].
How do you verify the product type and dose?
Changing products means the same numerical dose may not produce the same effect. Different products require different injection volumes and dilution protocols, necessitating technique adjustments.[2].
Ask the clinic to specify the product name and exactly how many units are being injected where. Storage, dilution method, and dose selection are also considered important for reducing side effects.[5].
What should be examined before injection?
Request assessment of muscle movement and prior treatments. A ultrasound study of 127 people's forehead and glabella muscles found individual variation in muscle thickness and depth, with some muscles showing depth differences by body type.[3].
People who have had facial surgery may have altered anatomy, making side effects more likely.[5]Always disclose past surgery or filler injections during consultation.
How are side effects managed?
Eyelid drooping typically appears 3–14 days after injection and resolves naturally around 3 months when the medication wears off.[1]Although it resolves, the appearance during that time can be distressing, so early consultation availability is important.[1].
Double vision is a rare side effect, estimated at 0.7–2.2% in patients treated for cosmetic purposes.[4]Small nodules (about 1 cm) have been reported after forehead injection, typically resolving naturally within 1–2 months.[6]It is reassuring to ask in advance whether there is a consultation option if such changes occur.
What precautions for repeat injections?
Effects typically last 3–4 months, varying with dose, injection method, and individual response.[7]Continued treatment requires repeat injections, so choosing a clinic where you can establish long-term care is important.
Long-term effects of repeated injection are not yet well understood.[8]A meta-analysis of 22 papers found few studies following patients beyond 6 months, and many were industry-supported.[9]Concern has been raised that prolonged use may reduce facial expressiveness.[7].
Where to get it—guidance when you are unsure
Ask these points during your consultation:
Experience: Does the injector understand facial muscle anatomy and have considerable injection experience?[1][2]
Explanation: Does the clinic specify the product name and exactly how many units are injected where?[2]
Examination: Does the clinic assess muscle movement and past surgery or filler injections?[3][5]
Technique: Does the clinic pay attention to injection placement and volume around the eyes?[4]
Follow-up: If eyelid drooping or nodules develop, can you receive follow-up care?[1][6]
Which muscles to inject and in what amount to preserve your natural expression, and whether your eyelids or brows are prone to drooping, cannot be determined from an article alone. At your examination, have the clinic evaluate your muscle movement when you make expressions and review your treatment history, then decide on placement and dose together.
- 1Jaime Alberto RP, Paola Andrea MA, Maria Paulina UP, Luisa LB. Iatrogenic Blepharoptosis: Multimodal Management and Treatment Technique With Botulinum Toxin Type A. Dermatology Research and Practice. 2025. doi:10.1155/drp/8827594
- 2Carruthers J, Glogau RG, Blitzer A. Advances in Facial Rejuvenation: Botulinum Toxin Type A, Hyaluronic Acid Dermal Fillers, and Combination Therapies—Consensus Recommendations. Plastic and Reconstructive Surgery. 2008. doi:10.1097/PRS.0b013e31816de8d0
- 3Jaguś D, Pawłowska A, Mlosek RK. Ultrasound Evaluation of Upper Facial Muscles to Guide Botulinum Toxin Application. Toxins. 2025. doi:10.3390/toxins17120595
- 4De-Pablo-Gómez-de-Liaño L, Ly-Yang F, Burgos-Blasco B, Fernández-Vigo JI. Ophthalmological Complications of Aesthetic Medicine Procedures: A Narrative Review. Journal of Clinical Medicine. 2025. doi:10.3390/jcm14155399
- 5Witmanowski H, Błochowiak K. The whole truth about botulinum toxin – a review. Advances in Dermatology and Allergology. 2019. doi:10.5114/ada.2019.82795
- 6Castelanich D, Parra LA, Rodriguez Cabrales JS, Cure E, Garces E, Parra AM. Toxin-Induced Nodules: A Clinically Distinct Complication With Implications for Aesthetic Practice. Case Reports in Dermatological Medicine. 2025. doi:10.1155/crdm/9921924
- 7Meretsky CR, Umali JP, Schiuma AT. A Systematic Review and Comparative Analysis of Botox Treatment in Aesthetic and Therapeutic Applications: Advantages, Disadvantages, and Patient Outcomes. Cureus. 2024. doi:10.7759/cureus.67961
- 8Neuhann-Lorenz C, Fedeles J, Eisenman-Klein M, Kinney B, Cunningham BL. Eighth IQUAM Consensus Conference Position Statement: Transatlantic Innovations, April 2009. Plastic and Reconstructive Surgery. 2011. doi:10.1097/prs.0b013e318206312e
- 9Crook JL, Hamidian Jahromi A, Konofaos P. Long-term Effects of Repeated Botulinum Toxin Injection in Cosmetic Therapeutics. Annals of Plastic Surgery. 2022. doi:10.1097/SAP.0000000000002994